Navigation Links
Radiologists encouraged to look beyond cancer for clinically unseen diseases

Radiologists can diagnose venous thromboembolic disease (VTED) in cancer patients earlier by looking more carefully at CT scans of the thorax, abdomen, and pelvis which are regularly done to determine the extent or stage of the cancer, according to a recent study conducted by radiologists at the University College Hospital in Galway, Ireland.

Venous thromboembolic disease can be fatal if left untreated. The study focused on pulmonary embolism (PE), inferior vena cava (IVC), and iliac and iliofemoral deep venous thromboses (DVTs) in oncology patients.

Wed noticed a number of clinically unsuspected deep venous thrombosis and pulmonary emboli on staging CT thorax, abdomen and pelvis examinations which goes unnoticed, said Carmel Cronin, MD, lead author of the study. When we do a CT to stage the cancer we can see both the pulmonary arterial system and the pelvic and lower extremity venous system, she said.

The study included 736 patients ranging from 20 to 79 years of age. According to the study, 23 patients had unsuspected iliofemoral DVT and four had common iliac vein involvement. The study also showed that 13 patients had an unsuspected pulmonary embolism.

We were surprised by the results, said Dr. Cronin. However, as outlined in other literature, the true prevalence of venous thromboembolic disease is underestimated as many are clinically unapparent. Venous thrombosis is estimated to be diagnosed in less than 40% of those with a concomitant venous thrombosis and malignancy, she said.


Contact: Necoya Lightsey
American Roentgen Ray Society

Page: 1

Related medicine news :

1. Radiologists Find New CT Scans Useful
2. Technology-enabled diagnosis by overseas radiologists
3. Computer Software Less Reliable Than Radiologists Eyes in Detecting Cancerous Tumors
4. Smokers Encouraged To Give Up The Habit
5. Fake Sun Tans Encouraged
6. Doctors Encouraged to Say, “I’m Sorry,” to Patients inUS
7. Seniors Encouraged To Make Use Of Medicare’s Freebie
8. Life Beyond Cancer - Delhi Woman Tells How
9. Intel Outside: Exploring Life beyond the Chip
10. Latest Drug for AMD, Beyond The Reach Of Common Man
11. Medical Course in Kerala is Beyond the Reach of NRIs
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: